DekaBank Deutsche Girozentrale’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-19,800
| Closed | -$372K | – | 1273 |
|
|
2019
Q3 | $372K | Sell |
19,800
-44,800
| -69% | -$512K | ﹤0.01% | 803 |
|
|
2019
Q2 | $730K | Buy |
64,600
+40,400
| +167% | +$489K | ﹤0.01% | 850 |
|
|
2019
Q1 | $432K | Buy |
24,200
+4,400
| +22% | +$57K | ﹤0.01% | 931 |
|
|
2018
Q4 | $203K | Sell |
19,800
-4,400
| -18% | -$56.3K | ﹤0.01% | 964 |
|
|
2018
Q3 | $432K | Sell |
24,200
-600
| -2% | -$10.8K | ﹤0.01% | 952 |
|
|
2018
Q2 | $391K | Hold |
24,800
| – | – | ﹤0.01% | 962 |
|
|
2018
Q1 | $300K | Sell |
24,800
-500
| -2% | -$7.23K | ﹤0.01% | 948 |
|
|
2017
Q4 | $234K | Hold |
25,300
| – | – | ﹤0.01% | 924 |
|
|
2017
Q3 | $234K | Hold |
25,300
| – | – | ﹤0.01% | 930 |
|
|
2017
Q2 | $304K | Hold |
25,300
| – | – | ﹤0.01% | 901 |
|
|
2017
Q1 | $533K | Sell |
25,300
-2,200
| -8% | -$48.7K | ﹤0.01% | 731 |
|
|
2016
Q4 | $575K | Buy |
27,500
+2,100
| +8% | +$54.6K | 0.01% | 638 |
|
|
2016
Q3 | $795K | Hold |
25,400
| – | – | 0.01% | 584 |
|
|
2016
Q2 | $618K | Buy |
25,400
+6,600
| +35% | +$179K | 0.01% | 637 |
|
|
2016
Q1 | $439K | Sell |
18,800
-3,300
| -15% | -$76.4K | 0.01% | 682 |
|
|
2015
Q4 | $752K | Buy |
22,100
+400
| +2% | +$13.5K | 0.01% | 613 |
|
|
2015
Q3 | $711K | Buy |
21,700
+3,300
| +18% | +$140K | 0.01% | 610 |
|
|
2015
Q2 | $975K | Buy |
18,400
+600
| +3% | +$21.8K | 0.01% | 572 |
|
|
2015
Q1 | $514K | Buy |
+17,800
| New | +$488K | 0.01% | 706 |
|
DekaBank Deutsche Girozentrale's ALDR Position: Q4 2019 in Review
DekaBank Deutsche Girozentrale sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 19,800 shares — an estimated $372K sold.
DekaBank Deutsche Girozentrale first reported a position in ALDR in Q1 2015 and held it in 19 quarters. The position peaked at $975K in Q2 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- DekaBank Deutsche Girozentrale reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 19,800 Alder Biopharmaceuticals shares in Q4 2019, an estimated $372K.
- DekaBank Deutsche Girozentrale first reported a position in Alder Biopharmaceuticals in Q1 2015 and held it in 19 quarters.
- DekaBank Deutsche Girozentrale's Alder Biopharmaceuticals position peaked at $975K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2019, filed 4 Feb 2020.